NAFLD is a leading cause of chronic liver disease worldwide. This Review discusses the diagnosis and stratification of patients with NAFLD by disease stage, and provides a stage-based approach to treatment. Pharmaceuticals in advanced development and potential future therapeutics are also addressed.
- Mary E. Rinella
- Arun J. Sanyal